Ashley Ngo, DO
Family Medicine · Sugar Land, TXNPI 1891374294
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 31.8% of the total.
Across 90 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$559
- IBSA Pharma Inc.$189
- Lilly USA, LLC$138
- Exact Sciences$102
- Dexcom, Inc.$99
- Takeda Pharmaceuticals U.S.A., Inc.$90
- plus $582 from 19 others
What the payments were for
- Food & beverage$1,760100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $559 |
| IBSA Pharma Inc. | 11 | $189 |
| Lilly USA, LLC | 7 | $138 |
| Exact Sciences | 5 | $102 |
| Dexcom, Inc. | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| AstraZeneca | 4 | $74 |
| GSK | 3 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Optinose US, Inc. | 2 | $46 |
| Shield Therapeutics Inc | 2 | $43 |
| Pfizer | 2 | $33 |
| Amgen | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| AbbVie | 2 | $29 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| Renalytix AI, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Alvogen Inc | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Merck | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$1,760 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Sugar Land
- Anne Marie Ponce de LeonSugar Land$109K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.